Omicron infections have a lower risk of long COVID than earlier variants, according to a study analyzing data from 11,000 participants.
The risk of developing long COVID is significantly lower following an infection with the Omicron variant than after an infection with earlier coronavirus variants. This was the finding of a study by University Medicine Halle, which was published in the International Journal of Infectious Diseases.
The analysis looked at information gathered from 11,000 people about their infection history, vaccination status, and post-infection symptoms. The data provide strong evidence that the risk for long-term effects after a re-infection with the coronavirus is lower if the patient did not develop long COVID after the initial infection.
Understanding Long COVID and its Relation to Variants
Long-term symptoms can develop after a coronavirus infection. This is commonly referred to as “long COVID” or “Post COVID-19 condition.” The underlying risk factors are currently under intensive investigation.
“We wanted to understand the connection between long COVID and different coronavirus variants, vaccinations, and past infections,” explains Sophie Diexer, first author of the new study and researcher at the Institute of Medical Epidemiology, Biometry and Informatics at University Medicine Halle. “Our study shows that the percentage of people who develop long COVID symptoms after an infection was lowest at the time when Omicron was prevalent.”
The risk was found to be around three to four times lower after an Omicron infection than after an infection with the wild-type variant. Around half of all wild-type infected individuals reported persisting symptoms. It should be noted, however, that the majority of all infections occurred while Omicron was dominant. “In purely numerical terms, this means that most people developed long COVID following an Omicron infection,” says Diexer.
Recovery and Reduced Risk
The study also provides strong evidence of a protective effect once the patient has recovered from a coronavirus infection. “People who did not develop persistent symptoms after their initial infection had a significantly lower risk of developing long COVID following re-infection than people who were infected with the coronavirus for the first time. We were surprised by the scale of this effect,” explains the researcher.
However, the scientists were unable to demonstrate that, in the event of a vaccine breakthrough, the vaccine had any protective effect against long COVID. Due to the timing of the study, however, it was not possible to analyze the vaccine that specifically targeted the Omicron variant.
Details and Background of the Study
The study is based on the Germany-wide DigiHero project, which more than 48,000 people participated in until June 2022. “Studies have already looked at the relationship between the risk of long COVID and the different variants, but none has taken into account infection history,” explains Professor Rafael Mikolajczyk, director of the Institute of Medical Epidemiology, Biometry and Informatics at University Medicine Halle.
“Of the respondents, approximately 11,000 reported at least one coronavirus infection that had occurred in the twelve weeks prior to when the data was collected for our study. Classification was based on the predominant variant at the time of the reported infection.”
Participants were questioned about 24 typical long COVID symptoms, with 2,822 individuals reporting that they had experienced such symptoms. Of these, 406 (14 percent) reported experiencing severe fatigue, 237 (8 percent ) severe headaches, and 202 (7 percent) severe shortness of breath. The intensity of the symptoms was not related to the coronavirus variant.
Future Investigations and DigiHero Project
Follow-up surveys are currently being conducted to explore the persistence of long COVID symptoms. “In addition to possible long-term symptoms following a coronavirus infection, DigiHero is addressing a wide range of health issues and other impacts of the COVID-19 pandemic,” adds Mikolajczyk.
On the basis of DigiHero, University Medicine Halle has also launched the Long COVID Registry in cooperation with Otto von Guericke University Magdeburg and the Rechts der Isar Hospital of the TUM School of Medicine. The registry records, for example, long COVID symptoms as well as their progression, severity, and alleviation through specific therapies.
Reference: “Association between Virus Variants, Vaccination, Previous Infections, and Post COVID-19 Risk” by Sophie Diexer, Bianca Klee, Cornelia Gottschick, Chao Xu, Anja Broda, Oliver Purschke, Mascha Binder, Thomas Frese, Matthias Girndt, Jessica I. Hoell, Irene Moor, Michael Gekle and Rafael Mikolajczyk, 25 August 2023, International Journal of Infectious Diseases.
DOI: 10.1016/j.ijid.2023.08.019
DigiHero is a Germany-wide, population-based digital health research study. To date, over 90,000 people from 14 German states have registered. Participants are invited to complete online surveys that explore issues surrounding the development of chronic disease, healthy aging, health behaviors, and the coronavirus. Five clinics and four institutes from University Medicine Halle are taking part. Other project partners include Jena University Hospital, the Leibniz Institute for Prevention Research and Epidemiology – BIPS, and the University of Bremen.
News
The Surprising Origin of a Deadly Hospital Infection
C. diff might not originate from external transmission but rather from within the infected patient themselves. Hospital staff dedicate significant effort to safeguard patients from infections during their hospital stay. Through practices ranging from [...]
Google AI breakthrough – huge step in finding genes that cause diseases
Google says it has made a significant step in identifying disease-causing genes, which could help spot rare genetic disorders. A new model named AlphaMissense is able to confidently classify 89 per cent of all [...]
New Study: Everyday Pleasures Can Boost Cognitive Performance
MINDWATCH study reveals cognitive peaks with everyday pleasures. Listening to music and drinking coffee are the sorts of everyday pleasures that can impact a person’s brain activity in ways that improve cognitive performance, including [...]
Moderna reveals new highly targeted COVID-19 vaccine mRNA-1283
Moderna has developed a new and improved version of its COVID-19 vaccine. The unique formulation (mRNA-1283) reduces the vaccine's content from the full-length SARS-CoV-2 spike protein to a narrowly focused encoding of just two [...]
New nanotech weapon takes aim at hard-to-treat breast cancer
Breast cancer in its various forms affects more than 250,000 Americans a year. One particularly aggressive and hard-to-treat type is triple-negative breast cancer (TNBC), which lacks specific receptors targeted by existing treatments. The rapid [...]
Scientists upcycle plastics into liquids that can store hydrogen energy
Scientists from Nanyang Technological University, Singapore (NTU Singapore) have created a process that can upcycle most plastics into chemical ingredients useful for energy storage, using light-emitting diodes (LEDs) and a commercially available catalyst, all [...]
Yale Scientists Uncover How the Immune System Can Alter Our Behavior
The mere scent of seafood can severely sicken those allergic to it — and therefore they are more likely to avoid it. Similarly, individuals who experience food poisoning from a specific dish tend to [...]
Whirlwind Tech – The Future of Energy-Efficient Spintronics Computing
Researchers in Germany and Japan have been able to increase the diffusion of magnetic whirls, so-called skyrmions, by a factor of ten. In today’s world, our lives are unimaginable without computers. Up until now, [...]
Omicron’s Silver Lining: Significantly Lower Risk of Long COVID
Omicron infections have a lower risk of long COVID than earlier variants, according to a study analyzing data from 11,000 participants. The risk of developing long COVID is significantly lower following an infection with [...]
The Hidden Mechanism Connecting Diabetes and Cancer
Researchers have discovered that insulin resistance, typically linked with type 2 diabetes, is also present in cancer patients and can accelerate the spread of the disease. In the 1920s, scientists found that the urine [...]
Scientists Unveil Urea’s Secret Role in the Origin of Life
Scientists from ETH Zurich and the University of Geneva have developed a new technique that allows them to observe chemical reactions taking place in liquids at extremely high temporal resolution. This innovation enables them to track how molecules [...]
Viagra Lowers Alzheimer’s Risk by Almost 70%, Early Study Finds
Research published recently suggests that Pfizer’s erectile dysfunction drug Viagra can decrease the risk of developing Alzheimer’s disease by up to 69 percent. The research, which was published in Nature, found that the medication has [...]
Future of Medical Imaging: Advanced AI Can Tell Your True Age by Looking at Your Chest
An AI-powered model utilizes chest X-rays to help develop biomarkers for aging. What if determining “your age” was based on your chest rather than your face? Scientists from Osaka Metropolitan University have crafted an [...]
Ultra-sensitive biosensors detect cancer in a blood test
Cancer biomarkers circulating in body fluids can be used for diagnosis and treatment monitoring. However, current detection technology lacks the required sensitivity, limiting biomarker use in clinical applications. Colorectal cancer is the second most [...]
Viruses cause 200+ diseases. This one drug may be able to treat them all.
By taking aim at a process common across many viruses, the drug could one day stop any number of known viruses — and new ones. t’s about as audacious an idea as you can [...]
Scientists Identify Potential Treatment for Rare and Devastating Lung Disease
The findings could lead to a cure for LAM. Researchers from the University of Cincinnati may have identified a potential treatment for lymphangioleiomyomatosis (LAM), a rare lung condition resembling cancer found predominantly in women of reproductive [...]
